Australia markets closed

Ortin Laboratories Limited (ORTINLAB.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
16.85-0.25 (-1.46%)
At close: 03:29PM IST

Ortin Laboratories Limited

D. No. 1-8-B4, F3 HIG
Ground Floor Block-4, Street no. 3 Baghlingampally
Hyderabad 500044
India
91 40 2756 2055
https://www.ortinlabsindia.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees24

Key executives

NameTitlePayExercisedYear born
Mr. Sanka Murali Krishna MurthyCEO & MDN/AN/A1959
Mr. Sanka Srinivasa KumarCFO & Whole Time DirectorN/AN/A1965
Ms. Divya PurswaniCompany Secretary & Compliance OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Ortin Laboratories Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Corporate governance

Ortin Laboratories Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.